{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:03:03Z","timestamp":1780329783942,"version":"3.54.1"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.msard.2026.107168","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T23:27:39Z","timestamp":1774826859000},"page":"107168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment on \u201cCalprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis\u201d"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-6045","authenticated-orcid":false,"given":"Sasikala","family":"Jummala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4138-858X","authenticated-orcid":false,"given":"Mohana","family":"Kumari C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1247-1294","authenticated-orcid":false,"given":"Deepti M","family":"Sati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107168_bib0001","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxad053","article-title":"Discrepancy in clinical and laboratory profiles of NMOSD patients between AQP4 antibody positive and negative: can NMOSD be diagnosed without AQP4 antibody?","author":"Chu","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107168_bib0002","article-title":"Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on \u201cChemokine CXCL13 in serum, CSF, and blood\u2013CSF barrier function","volume":"18","author":"DiSano","year":"2021","journal-title":"Fluid. Barrier. CNS"},{"key":"10.1016\/j.msard.2026.107168_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107163","article-title":"Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and Multiple sclerosis","author":"Johnsson","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2026.107168_bib0004","first-page":"107","article-title":"Variation in LOD across SARS-CoV-2 assay systems: need for standardization","volume":"52","author":"Sohni","year":"2021","journal-title":"Labmedicine"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600204X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600204X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:24:34Z","timestamp":1780327474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600204X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":4,"alternative-id":["S221103482600204X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107168","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201cCalprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis\u201d","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107168"}}